Studies assessing CSF biomarkers (Aβ1–42, total tau and phosphorylated) have reported similar findings in PCA compared with TAD [15–17, 34, 35], supporting the conclusion that PCA is associated with AD pathology. The gene discussed is MAPT; the disease is Alzheimer disease.